We are committed to supporting the best researchers.

An expert Research Advisory Committee (RAC) made up of leading clinicians and researchers from both Australia and abroad, independently review all submissions and score them against key requirements including our research priorities

The RAC present their recommendations to The Kids’ Cancer Project Board to make the final decision on which studies receive funding each financial year. The rules of the peer review process prohibit RAC members from endorsing their own projects.

Associate Professor David Ziegler MBBS UNSW, MD/PhD UNSW, Dip Paed, FRACP (Chair)
Associate Professor Ziegler is a senior Staff Specialist in the Kids Cancer Centre at Sydney Children’s Hospital, Randwick. He is a paediatric oncologist with expertise in neuro-oncology and early phase clinical trials. He has concurrent appointments as Group Leader at the Children’s Cancer Institute, and conjoint Associate Professor at the University of New South Wales.

Professor Jonathan G Izant PhD
Professor Izant has extensive international experience in biomedical research, business and non-profit leadership at Yale School of Medicine, Garvan Institute, QUT, Johnson & Johnson and the Bill & Melinda Gates Foundation. He has helped create biotech, bioinformatics and business development companies, was a member of the NHMRC Human Gene Advisory Panel and has served on numerous government and private research funding committees.

Dr Justine Stehn PhD
Dr Stehn is a Research Strategy Manager for SFI Research. She has over 20 years of field experience in understanding the role of the cell cytoskeleton in disease. She also has more than three years’ industry experience overseeing the clinical development of a novel drug technology for the treatment of adult and childhood cancers.

Dr Andrew Moore MBBS, FRACP, PhD
Dr Moore is a Paediatric Oncologist at the Lady Cilento Children's Hospital and Group Leader of the Childhood Leukaemia Research Laboratory at the University of Queensland Diamantina Institute, located within the Translational Research Institute (TRI). He is also Director of the Queensland Children's Tumour Bank, which collaborates with multiple cancer research groups nationally and internationally.

Professor Murray Norris AM BSc ANU, MAppSc NSWIT, PhD UNSW
Professor Norris was one of the first three scientists to staff the Children’s Cancer Institute when its research laboratories opened in 1984. He is Head of the Molecular Diagnostics Program and was appointed Deputy Director of Children’s Cancer Institute in 2000. He is also inaugural Director of the UNSW Centre for Childhood Cancer Research.

Dr Timothy P Cripe MD, PhD
Dr Cripe is a paediatric expert at Nationwide Children’s Hospital in Columbus, Ohio. His clinical interests include gene and viral therapies for solid tumours in children, including brain tumours, neuroblastoma, and bone and soft tissue sarcomas. Dr Cripe’s research focuses on developing and testing new, targeted therapies for paediatric solid tumours and translating those findings into clinical studies.

Dr Brenda Weigel MD, MSc
Dr Weigel is Director of the Division of Pediatric Haematology/Oncology at Masonic Cancer Centre, University of Minnesota (U of M). She is a professor cross-appointed at U of M’s Cancer Centre and the Department of Pediatrics, and the recipient of the Lehman/Children’s Cancer Research Fund Endowed Chair in Pediatric Cancer. She is also Chair of Developmental Therapeutics for the Children’s Oncology Group.

The Kids' Cancer Project is an ACNC Registered Charity 
ABN 13 061 138 181 | CFN 10581